Insights and real-world experience in biotech & pharma by ShaoChi Cheng — covering business development, market strategy, CDMO operations, and product commercialization. One article per week, no fluff
Most people evaluate opportunities by market size. But market size alone does not determine whether a business can survive. What truly matters is whether your operating model can convert demand into sustainable revenue that covers your costs.
In Asian business, alcohol is not just a drink, it serves as a medium to "lower the social barrier." It allows people from professional roles to true character, and it's often the key to move a partnership beyond contract to trust.
Is studying abroad worth it? Rethinking ROI, life choices, and optionality. It's a long-term asset rather than short-term investment. It takes time to reveal stronger networks and broader perspectives and not always immediate and financial.
How perfectionism and strategy overload nearly killed my writing habit as an content creator. How the military phrase: get it done first and make it good later helps me from perfectionism.
In the world of Business Development (BD), I’ve observed a fascinating difference between the "Western" and "Taiwanese" approach: Is it better to aim first, or fire immediately?
Learn how to find and develop high-value clients in CDMO business development, from global conferences to LinkedIn. Practical tactics for 6–24 month sales cycles, with real lessons on technical positioning, trust-building, and resilience.
What does Business Development (BD) actually do in biotech and pharma? From licensing deals to M&A, learn about the 5 core BD functions, daily responsibilities, and how BD differs from sales. A practical guide from an industry BD professional.
Practical strategies for Regional CDMOs to accelerate to global market and overcome Western biotech hesitation. Learn how specialization, GMP certifications, strategic partnerships, and industry networking can help small to mid-sized CDMOs become trusted partners in US, EU, and Japanese markets
Despite solid technology and competitive pricing, many Asian CDMOs struggle to win global clients. Here explores 5 deep-rooted structural barriers — regulatory hurdles, reputation building, geopolitical risks, communication challenges — prevent Asian CDMOs from achieving true globalization.
